ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 274

Frequency of Chronic Joint Pain Following Chikungunya Infection: A Colombian Cohort Study

Aileen Chang1, Liliana Encinales2, Alexandra Porras3, Nelly Pacheco2, St. Patrick Reid4, Karen Martins5, Shamila Pacheco2, Eyda Bravo2, Marianda Navarno2, Alejandro Rico Mendoza3, Richard Amdur6, Priyanka Kamalapathy6, Gary S. Firestein7, Jeffrey Bethony6 and Gary Simon6, 1Medicine, George Washington University, Washington, DC, 2Allied Research Society, Baranquilla, Colombia, 3Allied Research Society, Bogota, Colombia, 4University of Nebraska, Omaha, NE, 5United States Army Medical Research Institute of Infectious Disease, Frederick, MD, 6George Washington University, Washington, DC, 7Medicine, University of California San Diego, La Jolla, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: arthritis and viruses

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To estimate the frequency of chronic joint pain after infection with chikungunya virus in a Latin American cohort.

Methods: A cross sectional follow-up of a prospective cohort of 500 Chikungunya patients from Atlántico Department, Colombia clinically diagnosed with chikungunya during the 2014-2015 Colombian epidemic. Baseline and follow-up (20-months) symptoms were evaluated in serologically confirmed cases.

Results: Among 500 patients enrolled, 485 cases were serologically confirmed with chikungunya. Patients were predominantly adults (age 49 ± 16 years), female, had a high school or less level of education and were of mestizo ethnicity. The most commonly affected joints were the small joints including the wrists, ankles and fingers. The initial joint pain lasted a median of 4 days (IQR 3-8). Sixteen percent of participants reported missing a median of 4 days (IQR 2-7) of school or work. After 20-months, one fourth of the participants had persistent joint pain. A multivariate analysis indicated that significant predictors of persistent joint pain included college graduate status, initial symptoms of headache or knee pain, missed work, normal activities affected, 4 or more days of initial symptoms, and 4 or more weeks of initial pain.

Conclusion: This is the first report to describe the frequency of chikungunya-related arthritis in the Americas after a 20-month follow-up. The high frequency of chronic disease highlights the importance of development of prevention and treatment interventions.


Disclosure: A. Chang, None; L. Encinales, None; A. Porras, None; N. Pacheco, None; S. P. Reid, None; K. Martins, None; S. Pacheco, None; E. Bravo, None; M. Navarno, None; A. Rico Mendoza, None; R. Amdur, None; P. Kamalapathy, None; G. S. Firestein, Janssen Pharmaceutica Product, L.P., 2; J. Bethony, None; G. Simon, None.

To cite this abstract in AMA style:

Chang A, Encinales L, Porras A, Pacheco N, Reid SP, Martins K, Pacheco S, Bravo E, Navarno M, Rico Mendoza A, Amdur R, Kamalapathy P, Firestein GS, Bethony J, Simon G. Frequency of Chronic Joint Pain Following Chikungunya Infection: A Colombian Cohort Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/frequency-of-chronic-joint-pain-following-chikungunya-infection-a-colombian-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-chronic-joint-pain-following-chikungunya-infection-a-colombian-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology